Public Health

RSS
Sep 7
doctorswithoutborders:

Bayer Attempting To Block Affordable Patented Drugs In India
German pharmaceutical company Bayer is challenging an intellectual property decision in India that allows more affordable generic drugs to be produced in the interests of public health. You can see the extent of the price differences in this image.
Learn more about the case. 
Graphic by Will Owen

doctorswithoutborders:

Bayer Attempting To Block Affordable Patented Drugs In India

German pharmaceutical company Bayer is challenging an intellectual property decision in India that allows more affordable generic drugs to be produced in the interests of public health. You can see the extent of the price differences in this image.

Learn more about the case.

Graphic by Will Owen